Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
EN | CN

You are here:Home-Chemical Inhibitors & Agonists-Others-Other Targets-SWE101
SWE101

Chemical Structure : SWE101

CAS No.: 2376322-12-0

SWE101 (SWE-101, SWE 101)

Catalog No.: PC-73058Not For Human Use, Lab Use Only.

SWE101 (SWE-101, SWE 101) is a potent, selective, in vivo active inhibitor of soluble epoxide hydrolase (sEH) phosphatase domain (sEH-P) with IC50 of 58 nM.

Packing Price Stock Quantity
5 mg $258 In stock
10 mg $398 In stock
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

SWE101 (SWE-101, SWE 101) is a potent, selective, in vivo active inhibitor of soluble epoxide hydrolase (sEH) phosphatase domain (sEH-P) with IC50 of 58 nM.
SWE101 showed no significantactivity against sEH-H activity, did not inhibit either the hydrolase or phosphatase activity of mouse sEH.
SWE101 is active in rats with favorable pharmacokinetics and revealed the involvement of sEH-P in LPA hydrolysis.

Physicochemical Properties

M.Wt 376.233
Formula C19H15Cl2NO3
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

4-(4-(3,4-Dichlorophenyl)-5-phenyloxazol-2-yl)butanoic acid

References

1. Kramer JS, et al. J Med Chem. 2019 Sep 26;62(18):8443-8460.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: